Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OMNICELL, INC. Director's Dealing 2023

Mar 9, 2023

31980_dirs_2023-03-09_10bc793b-b952-4ef1-8020-8a5da402e676.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OMNICELL, INC. (OMCL)
CIK: 0000926326
Period of Report: 2023-03-07

Reporting Person: Bauer Joanne B (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-07 Common Stock M 19329 $25.53 Acquired 41211 Direct
2023-03-07 Common Stock S 9797 $53.9673 Disposed 31414 Direct
2023-03-07 Common Stock S 3318 $55.0377 Disposed 28096 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-03-07 Stock Option NQ (Right to Buy) $25.53 M 19329 Disposed 2023-12-31 Common Stock (19329) Direct

Footnotes

F1: The shares sold and reported on this Form 4 were sold to cover the exercise price and the reporting person's estimated tax liability.

F2: The price reported in Column 4 is a weighted average price of $53.9673. The sold price range between $53.60 to $54.52. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price of $55.0377. The sold price range between $54.60 to $55.3350. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.